Drug Type Recombinant LBP |
Synonyms Lactococcus lactis expressing human trefoil factor 1, Lactococcus lactis secreting human trefoil factor 1 + [1] |
Target |
Mechanism TFF1 stimulants(trefoil factor 1 stimulants), Bacteria replacements, Microbiome modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and Neck Neoplasms | Phase 2 | DE | 18 Jul 2017 | |
Head and Neck Neoplasms | Phase 2 | BE | 18 Jul 2017 | |
Head and Neck Neoplasms | Phase 2 | US | 18 Jul 2017 | |
Head and Neck Neoplasms | Phase 2 | GB | 18 Jul 2017 | |
Stomatitis | Phase 2 | DE | 18 Jul 2017 | |
Stomatitis | Phase 2 | US | 18 Jul 2017 | |
Stomatitis | Phase 2 | BE | 18 Jul 2017 | |
Stomatitis | Phase 2 | GB | 18 Jul 2017 |
Phase 2 | 200 | (AG013) | cxdhollysv(yuurhsxavd) = idxelsmtsa kesgxgezby (aakhbtocqj, zqejolwyzt - tnrgckkclg) View more | - | 23 Nov 2020 | ||
placebo (Placebo) | cxdhollysv(yuurhsxavd) = tcxrkgbili kesgxgezby (aakhbtocqj, iwrmqmpkfr - vxiqzutxvt) View more | ||||||
Phase 1 | 52 | ljkvyythyt(wnerbbmgvl) = wgqzfphriy krqguuabsn (zwvrvqkvfq ) View more | Positive | 15 Dec 2013 | |||
Placebo | - |